The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hormone therapy (HT) or capecitabine (CAP) as maintenance therapy following the first-line chemotherapy in HR+/HER2-ABC/MBC: Secondary endpoint adverse effects (AEs) and toxicity report of OVERSTEP Trial (ZJCH15001/CBCSG 035).
 
Jian Huang
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Xiying Shao
No Relationships to Disclose
 
Li Cai
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Lili Zhang
No Relationships to Disclose
 
Peng Shen
No Relationships to Disclose
 
Yanxia Shi
No Relationships to Disclose